Gynecologic Cancer Care
The Scott & White Cancer Institute includes a multidisciplinary team dedicated to treating gynecologic cancers, including cervical, uterine and ovarian cancers. As part of Scott & White's comprehensive women's health services, we provide you with innovative and leading-edge gynecologic care.
Each year, more than 9,000 women are diagnosed with cancer of the cervix. At Scott & White, we see an average of three new cervical cancers every month.
The treatment for cervical cancer depends on the stage the cancer is in when it is diagnosed. There are four stages of cervical cancer. We use the expertise of our gynecologic oncologists as well as technical information, including CT scans and PET scans, to assist us in the staging of our patients.
At Scott & White, we offer state-of-the-art treatment for all stages of cervical cancer, including:
- Surgical options
- External beam radiation
- Implant radiation (brachytherapy)
Uterine cancer is the most common invasive gynecologic cancer. At Scott & White, we treat an average of seven new uterine cancers every month.
Cancer of the uterus is diagnosed clinically, usually with a biopsy or with a dilation and curettage (D&C). Staging for uterine cancer is done surgically. Surgery usually consists of a total hysterectomy, removal of both tubes and ovaries and sampling of lymph nodes in the area.
Often times, surgery alone can be curative of uterine cancer. If further treatment is necessary, we offer state-of-the-art care in radiation therapy as well as chemotherapy.
Ovarian cancer is the fifth most common cancer among women, and it causes more deaths than any other type of female reproductive cancer. The cause is unknown. At any given time at Scott & White, we have approximately 40-50 patients who are actively being treated for ovarian cancer.